# VEEVA SYSTEMS - PHASE 1-2 DOUBT LIST & INVESTIGATION PRIORITIES

## CRITICAL DOUBTS & QUESTIONS

### üî¥ PRIORITY 1: TRADE SECRET LITIGATION & ESCALATING LEGAL COSTS
**Doubt Level**: HIGH - RED FLAG
**Current Status**: Ongoing lawsuit with significant financial impact

**Key Questions**:
1. What is the name of the case? Who are the defendants and plaintiffs?
2. What specific trade secrets are alleged to have been misappropriated?
3. Timeline: When did the case begin? What is the current status?
4. Why did litigation costs jump 6x YoY ($5M ‚Üí $30.6M in 9 months)?
5. Is this a single case or multiple litigation events?
6. What is the probability of loss? SEC disclosure of expected damages?
7. Has this case been settled or is it still active?

**Evidence Available**:
- 10-Q Q3 FY2026: $30.6M litigation charges (9 months)
- 10-Q prior year: ~$5M litigation charges (9 months)
- 10-K FY2025: Risk factor disclosure of potential "significant damages"
- Risk disclosure mentions trade secret misappropriation

**Investigation Approach**:
- Search SEC EDGAR for 8-K filings related to litigation
- Search court records (PACER, state courts) for case details
- WebSearch for: "VEEV Veeva trade secret lawsuit" + "VEEV litigation case"
- Check for contingent liability disclosure in 10-Q Item 1A

**Investment Concern**: Could indicate:
- Competitive vulnerability (why are trade secrets being stolen?)
- Management oversight gaps (security/IP protection)
- Potential material damages liability ($50M+?)
- Operational distraction for management

**Confidence of Investigation**: MEDIUM-HIGH
(Can find specific case details in court records and SEC filings)

---

### üî¥ PRIORITY 2: CRM PLATFORM MIGRATION RISKS & CUSTOMER DEFECTION
**Doubt Level**: MEDIUM-HIGH - STRATEGIC RISK
**Current Status**: Ongoing migration from Salesforce to proprietary Vault CRM (2024-2030)

**Key Questions**:
1. Why is Veeva migrating away from Salesforce after 15+ years?
   - Loss of strategic partnership? Margins too low? Technical limitations?
2. How many customers have already defected to Salesforce-IQVIA partnership?
3. What is the timeline and cost of the migration?
4. What is the actual risk to revenue if migration fails or loses customers?
5. Has Salesforce responded competitively? What are their product roadmaps?
6. Are there specific large customers already switching? Which ones?
7. What is the competitive position of Veeva Vault CRM vs. Salesforce platform?

**Evidence Available**:
- 10-K FY2025 Item 1A: Risk factor disclosure of CRM migration
- Professional services margin decline (22% ‚Üí 18%) could indicate customer disruption
- Top 10 customers = 28% of revenue (concentration risk if any switch)
- Salesforce-IQVIA partnership explicitly mentioned as competitive threat

**Investigation Approach**:
- WebSearch: "VEEV CRM migration Salesforce IQVIA partnership"
- WebSearch: "Veeva Vault CRM adoption customer reviews"
- Check 10-Q MD&A for any discussion of customer churn or migration adoption
- Look for 8-K announcements of major customer wins/losses
- Search for analyst reports on life sciences CRM competitive landscape

**Investment Concern**: Could indicate:
- Declining competitiveness of core CRM product
- Strategic misjudgment by Gassner/management
- Risk of significant revenue loss during migration
- Margin compression from migration costs and reduced sales
- Market share loss to Salesforce in core customer base

**Confidence of Investigation**: MEDIUM
(Some info in SEC filings, but detailed customer list likely proprietary)

---

### üü° PRIORITY 3: PROFESSIONAL SERVICES MARGIN COMPRESSION
**Doubt Level**: MEDIUM - OPERATIONAL EFFICIENCY CONCERN
**Current Status**: Margin decline from 22% to 18% in recent period

**Key Questions**:
1. What is causing the margin decline? (Pricing pressure? Higher costs? Customer demands?)
2. Is this a temporary effect or structural trend?
3. Are customers reducing implementation/service spending?
4. Is Veeva losing pricing power in services?
5. Has there been competitive pressure or commoditization?

**Evidence Available**:
- 10-K FY2025: Professional services margin baseline
- 10-Q Q3 FY2026: Current margin of 18% (4 percentage points lower)
- Potential connection: CRM migration disruption causing customer service needs
- Customer spending reductions in weaker biotech funding environment

**Investigation Approach**:
- Read 10-Q MD&A section carefully for management commentary
- Search for specific service delivery challenges or staffing issues
- Look for language about customer pricing negotiations
- Check if CRM migration is mentioned in context of service costs

**Investment Concern**: Could indicate:
- Erosion of high-margin services business
- Pricing power loss
- Customer economic stress
- Implementation challenges

**Confidence of Investigation**: MEDIUM-LOW
(Requires detailed MD&A analysis and potentially earnings call transcripts)

---

### üü° PRIORITY 4: MAJOR ACQUISITIONS & STRATEGIC TRANSACTIONS
**Doubt Level**: MEDIUM - HISTORICAL COMPLETENESS
**Current Status**: Not yet identified in Phase 1 research

**Key Questions**:
1. Has Veeva made any major acquisitions since IPO? If so:
   - What were the targets, prices, and years?
   - Were they successful or failures?
   - Any write-downs or impairments?
2. Are there any discontinued operations or divestitures?
3. Any significant failures in product development or market entries?

**Evidence Available**:
- 10-K FY2025: Business combination section
- SEC EDGAR 8-K filings for M&A announcements
- 10-Q MD&A for acquisition integration updates

**Investigation Approach**:
- Search 10-K Item 1 for "business combinations" or "acquisitions"
- Search SEC EDGAR for Veeva 8-K filings with "acquisition" keyword
- WebSearch: "VEEV Veeva acquisitions history"

**Confidence of Investigation**: HIGH
(All acquisition details must be disclosed in SEC filings)

---

### üü° PRIORITY 5: EXECUTIVE CHANGES & DEPARTURES
**Doubt Level**: MEDIUM - MANAGEMENT CONTINUITY
**Current Status**: Gassner confirmed as CEO as of 2025; prior executive changes unknown

**Key Questions**:
1. Has there been significant executive turnover?
2. Any departures of key product or sales leaders?
3. Any COO/President changes?
4. Any CFO or General Counsel changes?
5. Reason for departures (promotions, departures to competitors, resignations)?

**Evidence Available**:
- DEF 14A proxy 2025-05-05: Current executive officers
- Historical proxy statements (prior DEF 14As): Prior executive rosters
- 10-K Item 10: Executive officers and governance

**Investigation Approach**:
- Compare current DEF 14A against prior years' proxy statements
- WebSearch: "Veeva executive departures [executive names]"
- Check for 8-K filings announcing executive changes

**Confidence of Investigation**: MEDIUM-HIGH
(Proxy statements provide official documentation; can cross-check with news)

---

## PRIORITIZED INVESTIGATION SEQUENCE FOR PHASE 3

### PHASE 3 INVESTIGATIONS (TOP 2 ONLY)

**Investigation #1 (PRIMARY)**: Trade Secret Litigation
- **Reason**: Highest financial impact ($30.6M charges), biggest red flag, clearest evidence of problem
- **Investigation approach**: SEC filings + court records + WebSearch
- **Expected output**: Detailed case analysis with management signal assessment

**Investigation #2 (SECONDARY)**: CRM Platform Migration & Customer Defection
- **Reason**: Highest strategic risk to future revenue, indicates competitive weakness, ongoing effect
- **Investigation approach**: 10-K/10-Q analysis + WebSearch for customer/analyst commentary
- **Expected output**: Strategic risk assessment with competitive implications

### DEFER TO LATER PHASES
- Professional services margin compression (requires detailed MD&A + earnings call analysis)
- Major acquisitions history (lower priority if acquisition-light company)
- Executive changes (lower priority; continuity appears strong with founder CEO)

---

## CONFIDENCE LEVEL ASSESSMENT

| Doubt | Confidence Level | Source | Priority |
|-------|-----------------|--------|----------|
| Trade secret litigation details | MEDIUM | SEC Item 1A + PACER | üî¥ #1 |
| CRM migration risk/customer loss | MEDIUM | 10-K Item 1A + Market research | üî¥ #2 |
| Professional services margin cause | LOW | 10-Q MD&A | üü° #3 |
| Major acquisitions history | HIGH | 10-K Item 1 + 8-K filings | üü° #4 |
| Executive changes | MEDIUM-HIGH | Proxy statements | üü° #5 |

---

## INVESTIGATION RULES FOR PHASE 3

‚úÖ **DO**:
- Use SEC filings as primary evidence
- Use WebSearch for gaps only (MAX 2 searches)
- Find documentary evidence for "why" analysis
- Focus on TOP 2 doubts only
- Include confidence levels in findings
- Output max 4KB per investigation file

‚ùå **DON'T**:
- Guess at motivations without evidence
- Use training knowledge alone for analysis
- Investigate all 5 doubts (only top 2)
- Repeat timeline details from Phase 1
- Create files beyond the 2 investigations

---

**Doubt List Complete**: 5 critical doubts identified, ranked by priority
**Phase 3 Investigations**: Trade secret litigation + CRM migration (top 2)
**Next Step**: Execute Phase 3 investigations with evidence-based analysis

